Locations:

Tag: immune-related adverse events (irAEs)

October 10, 2022/Pulmonary/Critical Care

Case Study: Severe Toxicity Immunotherapy Highlights Multidisciplinary Oncology ICU Care

Immune toxicity remains a diagnosis of exclusion, and multidisciplinary collaboration remains the cornerstone for early diagnosis and treatment.

19-RHE-1355-ImmuneRel-advrs-CancerImlmunothrpy-hero

January 14, 2020/Rheumatology & Immunology/Immunologic Diseases

Chronic Inflammatory Arthritis: An Immune-Related Adverse Event from Cancer Immunotherapy

Proposing a classification system for irAEs

December 20, 2019/Rheumatology & Immunology/Rheumatic Diseases

Polymyalgia Rheumatica-Like Syndrome from Checkpoint Inhibitor Therapy

Same old disease or something different?

August 27, 2019/Rheumatology & Immunology/News & Insights

Rheumatic Immune-Related Adverse Events from Checkpoint Inhibitor Therapy: Update

irAEs are a formidable challenge

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

BackPage 1 of 1Next